NRX Pharmaceuticals (FRA:B1Q) Institutional Ownership: 9.62% (As of Sep. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B1Q NRX Pharmaceuticals Inc FRA:B1Q
33 GF Score
Price €2.88
! 2 Warning Signs
View Full Analysis

What is NRX Pharmaceuticals Institutional Ownership?

NRX Pharmaceuticals FRA:B1Q -6.49% 33 Institutional Ownership is 9.62% as of Sep. 07, 2026. GuruFocus rates FRA:B1Q with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NRX Pharmaceuticals's institutional ownership is 9.62%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NRX Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NRX Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 95.90%.

NRX Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for NRX Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NRX Pharmaceuticals Institutional Ownership Chart

NRX Pharmaceuticals Historical Data

The historical data trend for NRX Pharmaceuticals can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 4.91 5.58 4.60 5.13 6.13 7.68 8.32 8.85 7.71 9.62
FRA:B1Q
33GF Score
NRX Pharmaceuticals Inc FRA:B1Q
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NRX Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 9.62% mean?
NRX Pharmaceuticals (FRA:B1Q) has a Institutional Ownership of 9.62% as of Sep. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on NRX Pharmaceuticals and its competitors.
Is NRX Pharmaceuticals' Institutional Ownership too high?
NRX Pharmaceuticals' current Institutional Ownership is 9.62%. Overall, NRX Pharmaceuticals has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does NRX Pharmaceuticals' Institutional Ownership compare to INDP and EQ?
NRX Pharmaceuticals' Institutional Ownership of 9.62% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on NRX Pharmaceuticals and its competitors. NRX Pharmaceuticals's current Institutional Ownership is 9.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NRX Pharmaceuticals stock overvalued right now?
NRX Pharmaceuticals (FRA:B1Q) has a current Institutional Ownership of 9.62%. The current Institutional Ownership is 9.62%. NRX Pharmaceuticals' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For NRX Pharmaceuticals (FRA:B1Q), the current Institutional Ownership is 9.62% as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NRX Pharmaceuticals Business Description

Other Exchanges NRXP:USA
Address 1201 Orange Street, Suite 600, Wilmington, DE, USA, 19801
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
33GF Score

Get the complete analysis for FRA:B1Q

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.88
Price